 These lysine-like drugs interfere with the formation of the fibrinolytic enzyme plasmin from its precursor plasminogen by plasminogen activators (primarily t-PA and u-PA) which takes place mainly in lysine rich areas on the surface of fibrin.These drugs block the binding sites of the enzymes or plasminogen respectively and thus stop plasmin formation.They are used in menorrhagia and bleeding tendency due to various causes.